Inglés

Eligibility Prostate Cancer NCT00391950

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed diagnosis of carcinoma of the prostate
Descripción

Prostate carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0600139
no distant metastases
Descripción

Distant metastasis Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1269798
UMLS CUI [1,2]
C0332197
patients must be candidates for androgen deprivation therapy (adt)
Descripción

Indication Antiandrogen therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0279492
patient with a baseline bmd t-score at or below -1 standard deviations in the lumbar spine (l2-l4) are eligible
Descripción

Bone Mineral Density Test Lumbar spine T score

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0177804
UMLS CUI [1,2]
C3887615
UMLS CUI [1,3]
C3854607
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with normal bmd at trial entry
Descripción

Bone Mineral Density Normal

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0005938
UMLS CUI [1,2]
C0205307
patients who received any prior bisphosphonate therapy in the past 12 months
Descripción

Diphosphonates

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0012544
treatment with anti-androgen mono- or combination therapy
Descripción

Antiandrogen therapy | Antiandrogen therapy Combined

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0279492
UMLS CUI [2,1]
C0279492
UMLS CUI [2,2]
C0009429
patients who are currently receiving diethylstilbesterol (des) or who have previously received pc-spes
Descripción

Diethylstilbestrol | PC-SPES

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0012203
UMLS CUI [2]
C0756934
patients who have received prior treatment with systemic corticosteroids within the past 12 months
Descripción

CORTICOSTEROIDS FOR SYSTEMIC USE

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3653708
patients with prior exposure to anabolic steroids or growth hormone within the past 6 months
Descripción

Anabolic steroids Exposure to | Growth Hormone Exposure to

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0002845
UMLS CUI [1,2]
C0332157
UMLS CUI [2,1]
C0037663
UMLS CUI [2,2]
C0332157
patients with any prior treatment for osteoporosis
Descripción

Therapeutic procedure Osteoporosis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0029456
other protocol-defined inclusion/exclusion criteria may apply.
Descripción

Clinical Trial Eligibility Criteria Study Protocol

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Volver a la parte superior de la página

Similar models

Eligibility Prostate Cancer NCT00391950

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Prostate carcinoma
Item
histologically confirmed diagnosis of carcinoma of the prostate
boolean
C0600139 (UMLS CUI [1])
Distant metastasis Absent
Item
no distant metastases
boolean
C1269798 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Indication Antiandrogen therapy
Item
patients must be candidates for androgen deprivation therapy (adt)
boolean
C3146298 (UMLS CUI [1,1])
C0279492 (UMLS CUI [1,2])
Bone Mineral Density Test Lumbar spine T score
Item
patient with a baseline bmd t-score at or below -1 standard deviations in the lumbar spine (l2-l4) are eligible
boolean
C0177804 (UMLS CUI [1,1])
C3887615 (UMLS CUI [1,2])
C3854607 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Bone Mineral Density Normal
Item
patients with normal bmd at trial entry
boolean
C0005938 (UMLS CUI [1,1])
C0205307 (UMLS CUI [1,2])
Diphosphonates
Item
patients who received any prior bisphosphonate therapy in the past 12 months
boolean
C0012544 (UMLS CUI [1])
Antiandrogen therapy | Antiandrogen therapy Combined
Item
treatment with anti-androgen mono- or combination therapy
boolean
C0279492 (UMLS CUI [1])
C0279492 (UMLS CUI [2,1])
C0009429 (UMLS CUI [2,2])
Diethylstilbestrol | PC-SPES
Item
patients who are currently receiving diethylstilbesterol (des) or who have previously received pc-spes
boolean
C0012203 (UMLS CUI [1])
C0756934 (UMLS CUI [2])
CORTICOSTEROIDS FOR SYSTEMIC USE
Item
patients who have received prior treatment with systemic corticosteroids within the past 12 months
boolean
C3653708 (UMLS CUI [1])
Anabolic steroids Exposure to | Growth Hormone Exposure to
Item
patients with prior exposure to anabolic steroids or growth hormone within the past 6 months
boolean
C0002845 (UMLS CUI [1,1])
C0332157 (UMLS CUI [1,2])
C0037663 (UMLS CUI [2,1])
C0332157 (UMLS CUI [2,2])
Therapeutic procedure Osteoporosis
Item
patients with any prior treatment for osteoporosis
boolean
C0087111 (UMLS CUI [1,1])
C0029456 (UMLS CUI [1,2])
Clinical Trial Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Volver a la parte superior de la página